Acelrx announces underwritten public offering of common stock

Redwood city, calif., jan. 19, 2021 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx) (acelrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an underwritten public...

ACRX Ratings Summary

ACRX Quant Ranking